<DOC>
	<DOCNO>NCT01279785</DOCNO>
	<brief_summary>This single arm , open label study 20 patient prostate cancer schedule prostatectomy NIH Clinical Center . 123I-MIP-1072 image data evaluate visible uptake compare histopathology .</brief_summary>
	<brief_title>A Pilot Study 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging Men With Prostate Cancer Undergoing Prostatectomy</brief_title>
	<detailed_description>This exploratory , single arm , open label pilot study evaluation 123I-MIP-1072 intraprostatic uptake determination SPECT/CT imaging ( optional CGCP imaging ) , histological confirmation disease localization stag . Methodical evaluation 123I-MIP-1072 intraprostatic tumorous non-tumours region provide important preliminary data upon clinical study base . The optional additional CGCP imaging add , inherent potential high resolution scintigraphic detection 123I-MIP-1072 localization . This imaging feasibility data provide important preliminary information use CGCP image prostate cancer .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Participant must schedule undergo standard care prostatectomy presume localized prostate cancer NIH Clinical Center . Have undergo multiparametric endorectal coil 3T MR NIH clinical center Recent ( within 12 month study entry ) transrectal biopsy indicate presence adenocarcinoma prostate gland Participant must 18 year old . ECOG Performance grade 0 2 . ( see Appendix 1 ) Ability understand provide inform consent . All subject must sign document inform consent indicate understanding investigational nature risk study protocol relate study perform . Participants childbearing potential must agree use acceptable form birth control , define abstinence , barrier acceptable , effective contraceptive method 7 day infusion study drug . Participants participate would significantly delay schedule standard care therapy . Subjects must prostate biopsy perform within 12 week image ; within 8 week image provide absence hemorrhage confirm MR imaging . SGOT SGPT ≥ 2 x upper limit normal ; total bilirubin , ≥ 1.5 x upper limit normal ≥ 3.0 mg/dl patient Gilbert 's syndrome . Administered radioisotope within 5 physical half live prior study enrollment . Patients severe claustrophobia unresponsive oral anxiolytic Subjects weigh ≥350 lb unable fit within image gantry Subjects receive androgen deprivation therapy . Subjects medical condition circumstance , opinion Investigator , would significantly decrease obtain reliable data , achieve study objective complete study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Molecular Imaging</keyword>
	<keyword>PSMA</keyword>
	<keyword>adenocarcinoma</keyword>
	<keyword>prostatectomy</keyword>
</DOC>